The Journal of Organic Chemistry
Article
(EA:Hexane = 1:3) to afford the desired disaccharide 6o (39.5 mg,
78%) as a colorless oil.13b
(ddd, J1 = 9.3 Hz, J2 = 4.5 Hz, J3 = 2.3 Hz, 1H), 3.78−3.90 (m, 8H),
3.70−3.78 (m, 1H), 3.61 (dd, J1 = 9.4 Hz, J2 = 6.6 Hz, 1H), 1.76−1.84
(m, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ 160.2, 159.4, 144.4,
132.0, 130.3, 129.7, 129.6, 127.8, 127.5, 114.0, 113.7, 102.9, 102.0,
98.6, 76.5, 76.4, 74.8, 73.4, 70.6, 69.5, 68.9, 65.5, 55.3 ppm; HRMS
(ESI) calcd. for C28H32O9Na [M + Na]: 535.1944, found: 535.1943.
Ethyl(2R,3S,4R)-3-(4-methoxybenzyloxy)-2-(((4aR,6R,8aS)-2-(4-
methoxyphenyl)-4,4a,6,8a-tetrahydropyrano[3,2-d][1,3]dioxin-6-
yloxy)methyl)-3,4-dihydro-2H-pyran-4-yl Carbonate (8). To a
solution of compound 7 (0.2 mmol) in DCM (5 mL) was added
pyridine (1.0 mmol) at 0 °C. Then, ethyl chloroformate (0.8 mmol)
was added slowly. The mixture was allowed to warm to room
temperature and stir overnight. After the reaction was completed, the
solvent was removed under reduced pressure. The residue was purified
by column chromatography (EA:Hexane = 1:4) on silica gel to provide
compound 8 (99.4 mg, 85%) as a colorless oil. [α]2D3 = +43.3 (c = 1.0
in CHCl3); IR (neat) ν: 3022, 1649, 1616, 1522, 1417, 1243, 1128
cm−1; 1H NMR (400 MHz, CDCl3): δ 7.40−7.48 (m, 2H), 7.26−7.34
(m, 2H), 6.87−6.95 (m, 4H), 6.47 (dd, J1 = 6.1 Hz, J2 = 0.8 Hz, 1H),
6.15−6.22 (m, 1H), 5.66−5.74 (m, 1H), 5.57 (s, 1H), 5.38−5.44 (m,
1H), 5.27−5.35 (m, 1H), 4.87 (dd, J1 = 6.1 Hz, J2 = 3.0 Hz, 1H),
4.70−4.78 (m, 1H), 4.60−4.68 (m, 1H), 4.20−4.34 (m, 4H), 4.10−
4.15 (m, 1H), 4.04 (dd, J1 = 10.9 Hz, J2 = 2.7 Hz, 1H), 3.79−3.94 (m,
9H), 3.71−3.79 (m, 1H), 1.35 (t, J = 7.1 Hz, 3H) ppm; 13C NMR
(100 MHz, CDCl3): δ 160.1, 159.3, 154.6, 145.9, 131.9, 129.8, 129.7,
129.4, 127.7, 127.4, 113.8, 113.6, 101.9, 98.6, 98.5, 76.3, 74.8, 74.2,
73.0, 72.6, 70.5, 68.9, 65.0, 64.0, 55.2, 14.2 ppm; HRMS (ESI) calcd.
for C31H36O11Na [M + Na]: 607.2155, found: 607.2148.
tert-Butyl((2R,3R,4R)-3-(4-methoxybenzyloxy)-2-(((2R,5S,6R)-5-(4-
methoxybenzyloxy)-6-(((4aR,6R,8aS)-2-(4-methoxyphenyl)-
4,4a,6,8a-tetrahydropyrano[3,2-d][1,3]dioxin-6-yloxy)methyl)-5,6-
dihydro-2H-pyran-2-yloxy)methyl)-3,4-dihydro-2H-pyran-4-yloxy)-
dimethylsilane (9). To a mixture of DtBPF (0.02 mmol), Pd2(dba)3
(0.01 mmol), carbonate 8 (0.1 mmol), compound 5i (0.2 mmol), and
Cs2CO3 (0.2 mmol) was added toluene (2 mL) under an atmosphere
of argon. After stirring at 60 °C for 12 h, the solvent was removed
under reduced pressure to give a crude product that was further
purified by column chromatography (EA:CH2Cl2 = 1:10) to afford the
desired trisaccharide 9 (59.5 mg, 68%) as a colorless oil. [α]2D3 = +49.3
(c = 1.0 in CHCl3); IR (neat) ν: 3025, 1652, 1616, 1517, 1130 cm−1;
1H NMR (400 MHz, CDCl3): δ 7.38−7.45 (m, 2H), 7.21−7.29 (m,
((2S,3R,4S,5R,6R)-4,5-Bis(benzyloxy)-6-(benzyloxymethyl)-3-
((4aR,6S,8aS)-2-(4-methoxyphenyl)-4,4a,6,8a-tetrahydropyrano-
[3,2-d][1,3]dioxin-6-yloxy)tetrahydro-2H-pyran-2-yloxy)(tert-butyl)-
dimethylsilane (6p). Following the general procedure, the reaction
with DtBPF (9.5 mg, 0.02 mmol), Pd2(dba)3 (9.2 mg, 0.01 mmol),
carbonate 1 (33.6 mg, 0.1 mmol), compound 5p (113.0 mg, 0.2
mmol), and Cs2CO3 (65.2 mg, 0.2 mmol) in toluene (2 mL) at 60 °C
for 12 h gave a crude product that was further purified by column
chromatography (EA:Hexane = 1:4) to afford the desired disaccharide
6p (72.1 mg, 89%) as a colorless oil. [α]2D3 = +28.7 (c = 1.0 in CHCl3);
IR (neat) ν: 3016, 1650, 1614, 1520, 1252, 1214 cm−1; 1H NMR (400
MHz, CDCl3): δ 7.17−7.43 (m, 17H), 6.85−6.91 (m, 2H), 6.03 (d, J
= 10.3 Hz, 1H), 5.68−5.75 (m, 1H), 5.60−5.66 (m, 1H), 5.53 (s, 1H),
4.77−4.88 (m, 3H), 4.51−4.65 (m, 4H), 4.25−4.32 (m, 1H), 4.21 (dd,
J1 = 10.2 Hz, J2 = 4.5 Hz, 1H), 3.75−3.85 (m, 4H), 3.53−3.73 (m,
6H), 3.40−3.49 (m, 1H), 0.95 (s, 9H), 0.17 (s, 3H), 0.15 (s, 3H)
ppm; 13C NMR (100 MHz, CDCl3): δ 160.1, 138.3, 138.2, 138.0,
130.4, 129.8, 128.4(2C), 128.3, 127.9, 127.8, 127.7(2C), 127.5,
127.4(2C), 113.6, 101.9, 99.6, 97.0 84.6, 81.2, 78.2, 75.7, 74.9, 73.4,
70.8, 68.9(2C), 55.2, 25.7, 18.1, −4.1, −5.3 ppm; HRMS (ESI) calcd.
for C47H58O10NaSi [M + Na]: 833.3697, found: 833.3661.
(3aR,5R,5aS,8aS,8bR)-5-(((4aR,6R,8aS)-2-(4-Methoxyphenyl)-
4,4a,6,8a-tetrahydropyrano[3,2-d][1,3]dioxin-6-yloxy)methyl)-
2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4′,5′-
d]pyran (6q). Following the general procedure, the reaction with
DtBPF (9.5 mg, 0.02 mmol), Pd2(dba)3 (9.2 mg, 0.01 mmol),
carbonate 1 (33.6 mg, 0.1 mmol), compound 5q (52.1 mg, 0.2 mmol),
and Cs2CO3 (65.2 mg, 0.2 mmol) in toluene (2 mL) at 60 °C for 12 h
gave a crude product that was further purified by column
chromatography (EA:Hexane = 1:3) to afford the desired disaccharide
6q (42.0 mg, 83%) as a colorless oil.13b
(4aR,6S,8aS)-2-(4-Methoxyphenyl)-6-((2S,3S,4S,5R,6R)-2,4,5-tris-
(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-3-yloxy)-
4,4a,6,8a-tetrahydropyrano[3,2-d][1,3]dioxine (6r). Following the
general procedure, the reaction with DtBPF (9.5 mg, 0.02 mmol),
Pd2(dba)3 (9.2 mg, 0.01 mmol), carbonate 1 (33.6 mg, 0.1 mmol),
compound 5r (108.1 mg, 0.2 mmol), and Cs2CO3 (65.2 mg, 0.2
mmol) in toluene (2 mL) at 60 °C for 12 h gave a crude product that
was further purified by column chromatography (EA:Hexane = 1:3) to
afford the desired disaccharide 6r (27.5 mg, 35%) as a colorless oil.
[α]2D3 = +77.3 (c = 1.0 in CHCl3); IR (neat) ν: 3014, 1649, 1612, 1523,
4H), 6.83−6.92 (m, 6H), 6.30 (dd, J1 = 6.2 Hz, J2 = 0.8 Hz, 1H),
6.06−6.13 (m, 1H), 5.96−6.06 (m, 1H), 5.80−5.89 (m, 1H), 5.59−
5.67 (m, 1H), 5.52 (s, 1H), 5.29−5.34 (m, 1H), 5.07−5.15 (m, 1H),
4.72−4.80 (m, 1H), 4.64 (dd, J1 = 6.1 Hz, J2 = 2.7 Hz, 1H), 4.47−4.62
(m, 3H), 4.29−4.35 (m, 1H), 4.19−4.26 (m, 2H), 4.01−4.09 (m, 2H),
3.88−4.00 (m, 3H), 3.64−3.82 (m, 13H), 3.55−3.61 (m, 1H), 0.91 (s,
9H), 0.10 (s, 6H) ppm; 13C NMR (100 MHz, CDCl3): δ 160.1,
159.3(2C), 143.2, 131.4, 130.2, 130.1, 129.8, 129.5(2C), 128.7, 128.4,
128.2, 127.5, 113.9, 113.8, 113.7, 103.5, 102.0, 98.7, 96.0, 76.4, 76.3,
75.0, 74.9, 73.5, 70.5, 70.4, 69.0, 68.9, 68.8, 67.4, 66.5, 55.3, 55.2, 25.8,
17.9, −4.4, −4.6 ppm; HRMS (ESI) calcd. for C48H62O13Si [M + Na]:
897.3857, found: 897.3862.
1
1251, 1079 cm−1; H NMR (400 MHz, CDCl3): δ 7.23−7.43 (m,
20H), 7.14−7.19 (m, 2H), 6.86−6.92 (m, 2H), 6.13 (d, J = 10.3 Hz,
1H), 5.63−5.69 (m, 1H), 5.52−5.57 (m, 1H), 5.45 (s, 1H), 5.01−5.06
(m, 1H), 4.88 (d, J = 10.8 Hz, 1H), 4.69−4.76 (m, 2H), 4.61−4.69
(m, 2H), 4.46−4.58 (m, 3H), 4.05−4.16 (m, 3H), 3.93−3.99 (m, 1H),
3.87−3.93 (m, 1H), 3.70−3.87 (m, 6H), 3.60−3.69 (m, 1H), 3.47 (t, J
= 10.3 Hz, 1H) ppm; 13C NMR (100 MHz, CDCl3): δ 160.2,
138.4(2C), 138.3, 137.4, 132.2, 129.8, 128.4, 128.3(3C), 128.1, 127.9,
127.8, 127.6(2C), 127.5, 113.7, 101.9, 97.7(2C), 78.7, 75.1, 74.8, 73.4,
72.1, 71.8, 71.6, 70.6, 69.2, 68.7(2C), 55.3 ppm; HRMS (ESI) calcd.
for C48H50O10Na [M + Na]: 809.3302, found: 809.3300.
(4aR,6R,8aS)-6-(((2R,3S,6R)-6-Ethoxy-3-(4-methoxybenzyloxy)-
3,6-dihydro-2H-pyran-2-yl)methoxy)-2-(4-methoxyphenyl)-
4,4a,6,8a-tetrahydropyrano[3,2-d][1,3]dioxine (Byproduct 10).
From the synthesis of trisaccharide 9, byproduct compound 10
(13.5 mg, 25%) was purified by column chromatography (EA:CH2Cl2
= 1:10) as a colorless oil. [α]2D3 = +66.4 (c = 1.0 in CHCl3); IR (neat)
Preparation of Trisaccharide 9. (2R,3S,4R)-3-(4-Methoxy-
benzyloxy)-2-(((4aR,6R,8aS)-2-(4-methoxyphenyl)-4,4a,6,8a-tetra-
hydropyrano[3,2-d][1,3]dioxin-6-yloxy)methyl)-3,4-dihydro-2H-
pyran-4-ol (7). Compound 6l (0.5 mmol) was dissolved in THF (10
mL) under an atmosphere of N2, and the solution was cooled to 0 °C.
After stirring at 0 °C for 10 min, TBAF (1.0 M solution in THF, 0.7
mL) was added over a duration of 5 min. The mixture was then
allowed to warm to room temperature. After stirring for overnight, the
solvent was removed under reduced pressure to give a crude product
that was further purified by column chromatography (EA:Hexane =
1
ν: 3023, 1650, 1615, 1517, 1416, 1220, 1132 cm−1; H NMR (400
MHz, CDCl3): δ 7.38−7.46 (m, 2H), 7.21−7.29 (m, 2H), 6.83−6.94
(m, 4H), 6.09−6.16 (m, 1H), 5.92−6.05 (m, 1H), 5.79−5.87 (m, 1H),
5.67 (ddd, J1 = 10.3 Hz, J2 = 2.4 Hz, J3 = 1.5 Hz, 1H), 5.54 (s, 1H),
5.35−5.41 (m, 1H), 5.07−5.15 (m, 1H), 4.53−4.59 (m, 1H), 4.46−
4.53 (m, 1H), 4.21−4.30 (m, 2H), 3.87−4.00 (m, 4H), 3.67−3.86 (m,
9H), 3.51−3.62 (m, 1H), 1.23 (t, J = 7.1 Hz, 3H) ppm; 13C NMR
(100 MHz, CDCl3): δ 160.2, 159.4, 131.5, 130.0, 129.8, 129.5, 129.1,
128.4, 128.2, 127.5, 113.8, 113.7, 102.0, 98.8, 95.9, 75.1, 75.0, 70.6,
70.5, 69.1, 69.0, 67.4, 63.7, 55.3, 15.1 ppm; HRMS (ESI) calcd. for
C30H36O9Na [M + Na]: 563.2257, found: 563.2257.
1:2) to afford compound 7 (230.6 mg, 90%) as a colorless oil. [α]D23
=
+57.5 (c = 1.0 in CHCl3); IR (neat) ν: 3020, 1652, 1616, 1521, 1244,
1215 cm−1; H NMR (400 MHz, CDCl3): δ 7.39−7.45 (m, 2H),
1
7.27−7.33 (m, 2H), 6.86−6.94 (m, 4H), 6.37 (dd, J1 = 6.0 Hz, J2 = 1.4
Hz, 1H), 6.13−6.21 (m, 1H), 5.70 (ddd, J1 = 10.3 Hz, J2 = 2.4 Hz, J3 =
1.5 Hz, 1H), 5.55 (s, 1H), 5.40−5.46 (m, 1H), 4.68−4.79 (m, 3H),
4.22−4.39 (m, 3H), 4.09 (dd, J1 = 10.8 Hz, J2 = 2.3 Hz, 1H), 3.97
I
dx.doi.org/10.1021/jo502078c | J. Org. Chem. XXXX, XXX, XXX−XXX